Humacyte, Inc. (HUMA): 9 insider purchases in the last two years (4 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Apr 15, 2025 | Scheessele William John Officer | 6,493 | $1.54 | $10.0K | no history |
| Apr 14, 2025 | Parikh Shamik J Officer | 7,500 | $1.55 | $11.6K | no history |
| Apr 14, 2025 | Sander Dale A. Officer | 20,000 | $1.53 | $30.6K | no history |
| Apr 8, 2025 | Constantino Michael T. Director | 16,000 | $1.26 | $20.2K | opportunistic |
| Apr 8, 2025 | Green Charles Bruce Director | 6,000 | $1.29 | $7.7K | no history |
| Apr 8, 2025 | Sebelius Kathleen Director | 50,000 | $1.32 | $66.0K | no history |
| Dec 4, 2024 | Constantino Michael T. Director | 4,600 | $4.39 | $20.2K | opportunistic |
| Nov 21, 2024 | Dougan Brady W Director | 1,797 | $4.44 | $8.0K | opportunistic |
| Nov 21, 2024 | Niklason Laura E Director, Officer | 1,797 | $4.44 | $8.0K | opportunistic |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.